Taken together, although naïve MSCs and eMSCs-IL10 failed to rescue the body weight loss, the anti-inflammatory effects of eMSCs-IL10 in the GvHD model were revealed at a cellular level by the reduction of donor CD4+ and CD8+ T cells and suppression of pro-inflammatory cytokine secretion. Here, IL10 is linked to graft versus host disease.